Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models
| Autor: | Benmebarek, M., Karches, C., Schmidbauer, M., Kurzay, M., Klaus, R., Geiger, M., Rataj, F., Cadilha, B., Keyl, J., Lesch, S., Heise, C., Murr, R., vom Berg, J., Jastroch, M., Lamp, D., Niederfellner, G., Sustmann, C., Endres, S., Klein, C., Kobold, S. |
|---|---|
| Zdroj: | In European Journal of Cancer March 2018 92 Supplement 1:S20-S20 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect